Literature DB >> 16984816

The biology of the Gaucher cell: the cradle of human chitinases.

Anton P Bussink1, Marco van Eijk, G Herma Renkema, Johannes M Aerts, Rolf G Boot.   

Abstract

Gaucher disease (GD) is the most common lysosomal storage disorder and is caused by inherited deficiencies of glucocerebrosidase, the enzyme responsible for the lysosomal breakdown of the lipid glucosylceramide. GD is characterized by the accumulation of pathological, lipid laden macrophages, so-called Gaucher cells. Following the development of enzyme replacement therapy for GD, the search for suitable surrogate disease markers resulted in the identification of a thousand-fold increased chitinase activity in plasma from symptomatic Gaucher patients and that decreases upon successful therapeutic intervention. Biochemical investigations identified a single enzyme, named chitotriosidase, to be responsible for this activity. Chitotriosidase was found to be an excellent marker for lipid laden macrophages in Gaucher patients and is now widely used to assist clinical management of patients. In the wake of the identification of chitotriosidase, the presence of other members of the chitinase family in mammals was discovered. Amongst these is AMCase, an enzyme recently implicated in the pathogenesis of asthma. Chitinases are omnipresent throughout nature and are also produced by vertebrates in which they play important roles in defence against chitin-containing pathogens and in food processing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984816     DOI: 10.1016/S0074-7696(06)52001-7

Source DB:  PubMed          Journal:  Int Rev Cytol        ISSN: 0074-7696


  35 in total

1.  Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases.

Authors:  Anton P Bussink; Dave Speijer; Johannes M F G Aerts; Rolf G Boot
Journal:  Genetics       Date:  2007-08-24       Impact factor: 4.562

2.  Comparative functional analysis of the human macrophage chitotriosidase.

Authors:  Marylène Vandevenne; Vincent Campisi; Astrid Freichels; Carole Gillard; Gilles Gaspard; Jean-Marie Frère; Moreno Galleni; Patrice Filée
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

3.  Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity.

Authors:  Teresa Greenwell-Wild; Niki M Moutsopoulos; Maria Gliozzi; Efstathia Kapsogeorgou; Zoila Rangel; Peter J Munson; Haralampos M Moutsopoulos; Sharon M Wahl
Journal:  Arthritis Rheum       Date:  2011-10

4.  Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III.

Authors:  J Cox-Brinkman; M J van Breemen; B T van Maldegem; L Bour; W E Donker; C E M Hollak; F A Wijburg; J M F G Aerts
Journal:  J Inherit Metab Dis       Date:  2008-10-15       Impact factor: 4.982

5.  Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.

Authors:  Leelamma M Panicker; Diana Miller; Ola Awad; Vivek Bose; Yu Lun; Tea Soon Park; Elias T Zambidis; Judi A Sgambato; Ricardo A Feldman
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

6.  Serum chitotriosidase, a putative marker of chronically activated macrophages, increases with normal aging.

Authors:  Rohit Ramanathan; Anita Kohli; María Clara Ingaramo; Alka Jain; Sean X Leng; Naresh M Punjabi; Jeremy D Walston; Neal S Fedarko
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-03-22       Impact factor: 6.053

7.  Human chitinases and chitinase-like proteins as indicators for inflammation and cancer.

Authors:  Julia Kzhyshkowska; Alexei Gratchev; Sergij Goerdt
Journal:  Biomark Insights       Date:  2007-05-03

Review 8.  Production of chitooligosaccharides and their potential applications in medicine.

Authors:  Berit B Aam; Ellinor B Heggset; Anne Line Norberg; Morten Sørlie; Kjell M Vårum; Vincent G H Eijsink
Journal:  Mar Drugs       Date:  2010-04-27       Impact factor: 5.118

9.  Acetazolamide-based fungal chitinase inhibitors.

Authors:  Alexander W Schüttelkopf; Ludovic Gros; David E Blair; Julie A Frearson; Daan M F van Aalten; Ian H Gilbert
Journal:  Bioorg Med Chem       Date:  2010-10-08       Impact factor: 3.641

10.  Macrophage chitinase 1 stratifies chronic obstructive lung disease.

Authors:  Eugene Agapov; John T Battaile; Rose Tidwell; Ramsey Hachem; G Alexander Patterson; Richard A Pierce; Jeffrey J Atkinson; Michael J Holtzman
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.